Mandate

Vinge advises Axcel on its acquisition of Loopia and Active 24 from Visma

June 19, 2018 M&A

Vinge has advised the Nordic private equity firm Axcel on its acquisition of Visma’s hosting business, operating under the brands Loopia and Active 24.

Loopia and Active 24 are leading mass hosting providers and offer web domains, shared web hosting and value-added services such as security, e-commerce and Microsoft Office 365. The products are sold online on a prepaid subscription basis to around 350,000 SMEs and prosumer customers across primarily Sweden and the Czech Republic, with a further presence in Germany, Norway, the Netherlands, Serbia, Slovakia, Spain and the UK.
 
Vinge’s team consisted of partners Christina Kokko (M&A), Mikael Ståhl (Banking and Finance) and Eva Fredrikson (Commercial Agreements) together with associates Linda Sengul, Karl Klackenberg and Martin Cronsioe (M&A), Emelie Klefbeck, Josefine Larsson (Banking and Finance), Christoffer Nordin, Mathilda Persson, Isabell Nielsen, Jasmin Draszka-Ali, Lisa Hörnqvist, Moa Bodin (Commercial Agreements), Klara Secher (IP), Lova Unge, Sophia Holm (Employment), Kristoffer Larson (Real Estate), Daniel Wendelsson, Johan Wahlbom (Competition), Boris Kotur and Edin Agic (Corporate) and VDR assistant Jessica Öijer.
 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026